Cell Isolation Separation Market - Global Forecast to 2029
| 出版年月 | 2024年7月 |
| ページ数 | 476 |
| 図表数 | 693 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The cell isolation market is expected to grow to USD 8.4 billion by 2029, up from USD 4.6 billion in 2024, at a CAGR of 12.9% between 2024 and 2029.
細胞分離市場は、2024年の46億米ドルから2029年までに84億米ドルに成長し、2024年から2029年までのCAGRは12.9%になると予想されています。
Several significant factors contribute to the cell isolation market’s potential growth. Government support for cell-based research is increasing, as is the prevalence of cancer and infectious disorders. Furthermore, there is a growing focus on technological developments and personalized medicine. Furthermore, emerging countries provide significant development opportunities, and the increased emphasis on next-generation treatments is expected to drive the market further.
“The biomedical isolation segment accounted for the largest share of by application segment in 2023.”
In 2023, the biomedical isolation segment held the largest share of the global cell isolation market by application. Cell isolation is an important process for isolating biomolecules as it allows researchers to focus on specific cell populations and extract target molecules for further analysis, characterization, and use in therapeutic or research applications. Major factors driving the growth of the cell isolation market for biomolecule isolation are the increasing demand for biopharmaceutical products for the treatment of infectious and chronic diseases, innovative and advanced applications of cell analysis techniques in biomolecule isolation, and the growth of the global biopharmaceutical industry.
“In 2023, the US remained to dominate the cell isolation market.”
The US dominated the North American cell isolation market in 2023. The US is the world’s largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, growing focus on development of cell-based research due to growing prevalence of cancer is also driving the growth of the cell isolation market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
- By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Thermo Fisher Scientific Inc. (US)
- BD (US)
- Agilent Technologies, Inc. (US)
- Miltenyi Biotec (Germany)
- Revvity (US)
- Sartorius AG (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Lonza (Switzerland)
- QIAGEN (Netherlands)
- ALFA LAVAL (Sweden)
- Terumo Corporation (Japan)
- Corning Incorporated (US)
- Bio-Rad Laboratories, Inc. (US)
- GenScript (US)
- Bio-Techne (US)
- Takara Bio Inc. (Japan)
- Standard BioTools (US)
- Promega Corporation (US)
- Cell Signaling Technology, Inc. (US)
- STEMCELL Technologies (Canada)
Research Coverage:
This research report categorizes the cell isolation market by product (consumables (reagents, kits, media & sera, beads (magnetic beads and fluroscent beads), and disposables) and instruments(centrifuges, cell sorters, magnetic-activated cell seperator systems, and filtration systems)), cell type (human cells (differentiated cells and stem cells) and animal cells), cell source (adipose tissues, bone marrow, cord blood/ embryonic stem cells, and others), technique (centrifugation-based cell isolation, surface-based cell isolation, and filtration-based cell isolation), application (biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, in-vitro diagnostics, and others), end user (pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell isolation market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the cell isolation market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall cell isolation market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (surge in cases of cancer and infectious diseases and growing emphasis on technological advancements), restraints (ethical & safety issues and high cost of cell-based research), opportunities (growing focus on next generation sequencing), and Challenges (technical complexities and standardization issues) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the cell isolation market
- Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market
- Competitive Assessment: . Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), BD (US), Agilent Technologies, Inc. (US), Miltenyi Biotec (Germany), Revvity (US), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Lonza (Switzerland), QIAGEN (Netherlands), ALFA LAVAL (Sweden), Terumo Corporation (Japan), Corning Incorporated (US), Bio-Rad Laboratories, Inc. (US), GenScript (US), Bio-Techne (US), Takara Bio Inc. (Japan), Standard BioTools (US), Promega Corporation (US), Cell Signaling Technology, Inc. (US), and STEMCELL Technologies (Canada), among others in the market.
Report Overview
1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS AND EXCLUSIONS 42
1.3 STUDY SCOPE 43
1.3.1 SEGMENTS COVERED 43
1.3.2 REGIONS COVERED 44
1.3.3 YEARS CONSIDERED 44
1.3.4 CURRENCY CONSIDERED 45
1.3.4.1 Value unit 45
1.3.4.2 Volume unit 45
1.4 STAKEHOLDERS 45
1.5 SUMMARY OF CHANGES 45
1.6 RECESSION IMPACT 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
2.1.1 SECONDARY DATA 48
2.1.2 PRIMARY DATA 48
2.2 MARKET SIZE ESTIMATION METHODOLOGY 50
2.2.1 BOTTOM-UP APPROACH 50
2.2.2 TOP-DOWN APPROACH 53
2.3 GROWTH RATE PROJECTIONS 54
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 57
2.5 RESEARCH ASSUMPTIONS 58
2.6 RESEARCH LIMITATIONS 58
2.7 RISK ANALYSIS 59
2.8 RECESSION IMPACT ANALYSIS 59
3 EXECUTIVE SUMMARY 61
4 PREMIUM INSIGHTS 67
4.1 CELL ISOLATION MARKET OVERVIEW 67
4.2 NORTH AMERICAN CELL ISOLATION MARKET, BY TYPE AND COUNTRY 68
4.3 CELL ISOLATION MARKET SHARE, BY APPLICATION 69
4.4 CELL ISOLATION MARKET SHARE, BY END USER 69
4.5 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
5.2.1 DRIVERS 72
5.2.1.1 Increasing government funding for cell-based research 72
5.2.1.2 Surge in cases of cancer and infectious diseases 73
5.2.1.3 Rising emphasis on technological advancements and product developments 75
5.2.1.4 Growing focus on personalized medicine 75
5.2.2 RESTRAINTS 76
5.2.2.1 Ethical and safety issues 76
5.2.2.2 High cost of cell-based research 77
5.2.3 OPPORTUNITIES 77
5.2.3.1 Growth opportunities in emerging economies 77
5.2.3.2 Increasing focus on next-generation therapeutics 78
5.2.4 CHALLENGES 79
5.2.4.1 Complex development process of cell therapies 79
5.2.4.2 Technical complexities and stringent regulatory requirements 79
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79
5.4 TECHNOLOGY ANALYSIS 80
5.4.1 KEY TECHNOLOGIES 80
5.4.1.1 Centrifugation-based techniques 80
5.4.1.2 Magnetic cell isolation 80
5.4.1.3 Fluorescence-activated cell sorting 80
5.4.1.4 Acoustic cell isolation 80
5.4.1.5 Acoustofluidic cell isolation 80
5.4.1.6 Microfiltration 81
5.4.2 COMPLEMENTARY TECHNOLOGIES 81
5.4.2.1 Mass cytometry 81
5.4.2.2 Cell imaging technologies 81
5.4.2.3 Artificial intelligence and machine learning 81
5.4.3 ADJACENT TECHNOLOGIES 81
5.4.3.1 Single-cell sequencing 81
5.4.3.2 Clustered regularly interspaced short palindromic repeats
and gene editing 81
5.4.3.3 3D cell culture 82
5.5 PRICING ANALYSIS 82
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 82
5.5.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE 83
5.5.3 AVERAGE SELLING PRICE TREND, BY REGION 84
5.6 VALUE CHAIN ANALYSIS 84
5.7 PATENT ANALYSIS 86
5.8 SUPPLY CHAIN ANALYSIS 88
5.9 ECOSYSTEM ANALYSIS 89
5.9.1 ROLE OF RAW MATERIAL VENDORS 90
5.9.2 ROLE OF PRODUCT PROVIDERS 90
5.9.3 ROLE OF END USERS 91
5.9.4 ROLE OF REGULATORY AUTHORITIES 91
5.10 REGULATORY LANDSCAPE 92
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
5.10.2 REGULATORY SCENARIO 95
5.11 PORTER’S FIVE FORCES ANALYSIS 97
5.11.1 THREAT OF NEW ENTRANTS 98
5.11.2 THREAT OF SUBSTITUTES 98
5.11.3 BARGAINING POWER OF SUPPLIERS 98
5.11.4 BARGAINING POWER OF BUYERS 98
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 99
5.12 KEY CONFERENCES AND EVENTS, 2024–2025 99
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 101
5.13.1 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 101
5.13.2 BUYING CRITERIA 102
5.14 TRADE ANALYSIS 103
5.14.1 IMPORT DATA FOR HS CODE 382200 103
5.14.2 EXPORT DATA FOR HS CODE 382200 105
5.15 INVESTMENT AND FUNDING SCENARIO 107
5.16 IMPACT OF GENERATIVE AI ON CELL ISOLATION MARKET 107
6 CELL ISOLATION MARKET, BY PRODUCT 109
6.1 INTRODUCTION 110
6.2 CONSUMABLES 110
6.2.1 REAGENTS, KITS, MEDIA, AND SERA 114
6.2.1.1 Surge in product launches and repetitive purchases to boost segment growth 114
6.2.2 BEADS 118
6.2.2.1 Magnetic beads 121
6.2.2.1.1 Growing demand in biomedical research and clinical applications to drive market 121
6.2.2.2 Fluorescent beads 124
6.2.2.2.1 Increasing use in flow cytometry, cell sorting, and imaging applications to fuel market 124
6.2.3 DISPOSABLES 128
6.2.3.1 Growing government investments in research to aid market growth 128
6.3 INSTRUMENTS 131
6.3.1 CENTRIFUGES 135
6.3.1.1 Growing use in pharma-biotech industry to boost market 135
6.3.2 CELL SORTERS 139
6.3.2.1 Rise in cell-based research initiatives to augment growth 139
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 143
6.3.3.1 Booming use in research for T-cell and stem cell isolation to drive market 143
6.3.4 FILTRATION SYSTEMS 147
6.3.4.1 Rising need to ensure Good Manufacturing Practice standards and regulations to boost market 147
7 CELL ISOLATION MARKET, BY CELL TYPE 151
7.1 INTRODUCTION 152
7.2 HUMAN CELLS 152
7.2.1 DIFFERENTIATED CELLS 156
7.2.1.1 Increasing use in disease modeling, regenerative medicine, and gene therapy to fuel growth 156
7.2.2 STEM CELLS 160
7.2.2.1 Rise in grants and funding for stem cell research to drive market 160
7.3 ANIMAL CELLS 163
7.3.1 GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH 163
8 CELL ISOLATION MARKET, BY CELL SOURCE 167
8.1 INTRODUCTION 168
8.2 ADIPOSE TISSUE 168
8.2.1 INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET 168
8.3 BONE MARROW 172
8.3.1 GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH 172
8.4 CORD BLOOD/EMBRYONIC STEM CELLS 175
8.4.1 HIGH THERAPEUTIC POTENCY TO SUPPORT MARKET GROWTH 175
8.5 OTHER CELL SOURCES 178
9 CELL ISOLATION MARKET, BY TECHNIQUE 182
9.1 INTRODUCTION 183
9.2 CENTRIFUGATION-BASED CELL ISOLATION 183
9.2.1 RISE IN USE BY BIOTECH AND BIOPHARMACEUTICAL COMPANIES TO FUEL MARKET 183
9.3 SURFACE MARKER-BASED CELL ISOLATION 187
9.3.1 INCREASING ADOPTION OF MAGNETIC-ACTIVATED CELL SORTING TO PROPEL MARKET 187
9.4 FILTRATION-BASED CELL ISOLATION 191
9.4.1 NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET 191
10 CELL ISOLATION MARKET, BY APPLICATION 195
10.1 INTRODUCTION 196
10.2 BIOMOLECULE ISOLATION 196
10.2.1 INCREASING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS TO FUEL MARKET 196
10.3 CANCER RESEARCH 200
10.3.1 GROWING INCLINATION TOWARD DEVELOPING AND MANUFACTURING CANCER TREATMENTS TO DRIVE MARKET 200
10.4 STEM CELL RESEARCH 203
10.4.1 RISING GRANTS AND FUNDING FOR STEM CELL RESEARCH TO AUGMENT GROWTH 203
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 207
10.5.1 GROWING INITIATIVES FOR RESEARCH IN REGENERATIVE MEDICINE TO SUPPORT MARKET 207
10.6 IN VITRO DIAGNOSTICS 210
10.6.1 NEED FOR ACCURACY TO IDENTIFY CELL TYPE TO PROPEL MARKET 210
10.7 OTHER APPLICATIONS 214
11 CELL ISOLATION MARKET, BY END USER 218
11.1 INTRODUCTION 219
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 219
11.2.1 INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH 219
11.3 ACADEMIC & RESEARCH INSTITUTES 223
11.3.1 HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT 223
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES 227
11.4.1 INCREASING NUMBER OF HEALTHCARE FACILITIES IN EMERGING ECONOMIES TO DRIVE MARKET 227
11.5 OTHER END USERS 231
12 CELL ISOLATION MARKET, BY REGION 234
12.1 INTRODUCTION 235
12.2 NORTH AMERICA 235
12.2.1 NORTH AMERICA: RECESSION IMPACT 241
12.2.2 US 241
12.2.2.1 Rising prevalence of cancer to drive market 241
12.2.3 CANADA 245
12.2.3.1 Increased government funding for stem cell and vaccine research to propel market 245
12.3 EUROPE 250
12.3.1 EUROPE: RECESSION IMPACT 254
12.3.2 GERMANY 254
12.3.2.1 Rising interest in biotechnology drugs and applications to aid market growth 254
12.3.3 UK 259
12.3.3.1 Increasing prevalence of infectious diseases to drive market 259
12.3.4 FRANCE 263
12.3.4.1 Surge in investments in cell biology research activities to drive market 263
12.3.5 ITALY 268
12.3.5.1 Rising number of cell biology seminars and conferences to drive market 268
12.3.6 SPAIN 272
12.3.6.1 Increasing funding from private and public organizations to aid growth 272
12.3.7 REST OF EUROPE 277
12.4 ASIA PACIFIC 281
12.4.1 ASIA PACIFIC: RECESSION IMPACT 285
12.4.2 CHINA 286
12.4.2.1 Increasing investments in research and technological advancements to boost market 286
12.4.3 JAPAN 290
12.4.3.1 Dominant geriatric population to aid market growth 290
12.4.4 INDIA 295
12.4.4.1 Growing penetration of healthcare insurance services to propel market 295
12.4.5 AUSTRALIA 299
12.4.5.1 Growing emphasis on personalized medicine, biopharmaceuticals, and advanced therapies to fuel market 299
12.4.6 SOUTH KOREA 303
12.4.6.1 Rising need for therapeutics to support market growth 303
12.4.7 REST OF ASIA PACIFIC 307
12.5 LATIN AMERICA 312
12.5.1 LATIN AMERICA: RECESSION IMPACT 316
12.5.2 BRAZIL 316
12.5.2.1 Need to improve public access to modern healthcare facilities to drive market 316
12.5.3 MEXICO 321
12.5.3.1 Favorable trade agreements to support market 321
12.5.4 REST OF LATIN AMERICA 325
12.6 MIDDLE EAST 329
12.6.1 MIDDLE EAST: RECESSION IMPACT 333
12.6.2 GCC 334
12.6.2.1 Saudi Arabia 338
12.6.2.1.1 Growing focus on Vision 2030 initiatives to boost market 338
12.6.2.2 UAE 342
12.6.2.2.1 Rising inclination toward producing high-value specialty drugs to aid market growth 342
12.6.2.3 Rest of GCC Countries 346
12.6.3 REST OF MIDDLE EAST 351
12.7 AFRICA 355
12.7.1 INCREASING PATIENT POPULATION WITH CANCER TO PROPEL MARKET 355
12.7.2 AFRICA: RECESSION IMPACT 359
13 COMPETITIVE LANDSCAPE 360
13.1 OVERVIEW 360
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 360
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET 361
13.3 REVENUE ANALYSIS, 2021–2023 363
13.4 MARKET SHARE ANALYSIS, 2023 363
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 365
13.5.1 STARS 366
13.5.2 EMERGING LEADERS 366
13.5.3 PERVASIVE PLAYERS 366
13.5.4 PARTICIPANTS 366
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 368
13.5.5.1 Company footprint 368
13.5.5.2 Region footprint 369
13.5.5.3 Type footprint 370
13.5.5.4 Cell type footprint 371
13.5.5.5 End user footprint 372
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 373
13.6.1 PROGRESSIVE COMPANIES 373
13.6.2 RESPONSIVE COMPANIES 373
13.6.3 DYNAMIC COMPANIES 373
13.6.4 STARTING BLOCKS 373
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 375
13.7 COMPANY VALUATION AND FINANCIAL METRICS 377
13.8 BRAND/PRODUCT COMPARISON 378
13.9 COMPETITIVE SCENARIO 379
13.9.1 PRODUCT LAUNCHES 379
13.9.2 DEALS 380
13.9.3 EXPANSIONS 381
13.9.4 OTHER DEVELOPMENTS 382
14 COMPANY PROFILES 383
14.1 KEY PLAYERS 383
14.1.1 DANAHER CORPORATION 383
14.1.1.1 Business overview 383
14.1.1.2 Products offered 384
14.1.1.3 Recent developments 385
14.1.1.3.1 Deals 385
14.1.1.4 MnM view 385
14.1.1.4.1 Key strengths 385
14.1.1.4.2 Strategic choices 385
14.1.1.4.3 Weaknesses and competitive threats 386
14.1.2 MERCK KGAA 387
14.1.2.1 Business overview 387
14.1.2.2 Products offered 388
14.1.2.3 Recent developments 389
14.1.2.3.1 Deals 389
14.1.2.3.2 Expansions 389
14.1.2.4 MnM view 390
14.1.2.4.1 Key strengths 390
14.1.2.4.2 Strategic choices 390
14.1.2.4.3 Weaknesses and competitive threats 390
14.1.3 THERMO FISHER SCIENTIFIC INC. 391
14.1.3.1 Business overview 391
14.1.3.2 Products offered 393
14.1.3.3 Recent developments 397
14.1.3.3.1 Product launches 397
14.1.3.3.2 Deals 398
14.1.3.3.3 Expansions 399
14.1.3.4 MnM view 399
14.1.3.4.1 Key strengths 399
14.1.3.4.2 Strategic choices 399
14.1.3.4.3 Weaknesses and competitive threats 399
14.1.4 BD 400
14.1.4.1 Business overview 400
14.1.4.2 Products offered 401
14.1.4.3 Recent developments 404
14.1.4.3.1 Product launches 404
14.1.4.3.2 Deals 404
14.1.4.3.3 Other developments 405
14.1.5 SARTORIUS AG 406
14.1.5.1 Business overview 406
14.1.5.2 Products offered 407
14.1.5.3 Recent developments 409
14.1.5.3.1 Deals 409
14.1.6 AGILENT TECHNOLOGIES, INC. 410
14.1.6.1 Business overview 410
14.1.6.2 Products offered 411
14.1.6.3 Recent developments 412
14.1.6.3.1 Deals 412
14.1.7 BIO-RAD LABORATORIES, INC. 413
14.1.7.1 Business overview 413
14.1.7.2 Products offered 415
14.1.7.3 Recent developments 416
14.1.7.3.1 Product launches 416
14.1.8 QIAGEN 417
14.1.8.1 Business overview 417
14.1.8.2 Products offered 418
14.1.8.3 Recent developments 419
14.1.8.3.1 Deals 419
14.1.9 F. HOFFMANN-LA ROCHE LTD. 420
14.1.9.1 Business overview 420
14.1.9.2 Products offered 422
14.1.10 REVVITY 423
14.1.10.1 Business overview 423
14.1.10.2 Products offered 425
14.1.10.3 Recent developments 427
14.1.10.3.1 Other developments 427
14.1.11 CORNING INCORPORATED 428
14.1.11.1 Business overview 428
14.1.11.2 Products offered 430
14.1.12 LONZA 431
14.1.12.1 Business overview 431
14.1.12.2 Products offered 432
14.1.12.3 Recent developments 433
14.1.12.3.1 Product launches 433
14.1.12.3.2 Deals 433
14.1.13 BIO-TECHNE 434
14.1.13.1 Business overview 434
14.1.13.2 Products offered 435
14.1.13.3 Recent developments 437
14.1.13.3.1 Deals 437
14.1.13.3.2 Other developments 437
14.1.14 TERUMO CORPORATION 438
14.1.14.1 Business overview 438
14.1.14.2 Products offered 440
14.1.14.3 Recent developments 440
14.1.14.3.1 Deals 440
14.1.15 MILTENYI BIOTEC 441
14.1.15.1 Business overview 441
14.1.15.2 Products offered 441
14.1.16 TAKARA BIO INC. 443
14.1.16.1 Business overview 443
14.1.16.2 Products offered 444
14.1.16.3 Recent developments 446
14.1.16.3.1 Deals 446
14.1.17 GENSCRIPT 447
14.1.17.1 Business overview 447
14.1.17.2 Products offered 448
14.1.17.3 Recent developments 450
14.1.17.3.1 Deals 450
14.1.18 STANDARD BIOTOOLS 451
14.1.18.1 Business overview 451
14.1.18.2 Products offered 452
14.1.19 ALFA LAVAL 453
14.1.19.1 Business overview 453
14.1.19.2 Products offered 454
14.1.19.3 Recent developments 455
14.1.19.3.1 Product launches 455
14.1.19.3.2 Deals 456
14.2 OTHER PLAYERS 457
14.2.1 PROMEGA CORPORATION 457
14.2.2 CELL SIGNALING TECHNOLOGY, INC. 458
14.2.3 MICAREO INC. 458
14.2.4 APPLIED CELLS INC. 459
14.2.5 STEMCELL TECHNOLOGIES 460
14.2.6 CREATIVE BIOARRAY 461
14.2.7 PROTEINTECH GROUP, INC. 461
14.2.8 MAGBIO GENOMICS, INC. 462
14.2.9 AKADEUM LIFE SCIENCES 463
14.2.10 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG 464
14.2.11 INVENT BIOTECHNOLOGIES, INC. 465
15 APPENDIX 466
15.1 DISCUSSION GUIDE 466
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 472
15.3 CUSTOMIZATION OPTIONS 474
15.4 RELATED REPORTS 474
15.5 AUTHOR DETAILS 475
LIST OF TABLES
TABLE 1 CELL ISOLATION MARKET: INCLUSIONS AND EXCLUSIONS 42
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 55
TABLE 3 IMPACT ANALYSIS OF MARKET DYNAMICS 72
TABLE 4 NATIONAL INSTITUTES OF HEALTH FUNDING FOR CELL-BASED RESEARCH,
2019–2025 (USD MILLION) 73
TABLE 5 CANCER INCIDENCE WORLDWIDE, 2020 VS. 2040 74
TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015–2022 76
TABLE 7 INVESTMENT ROUNDS IN ASIA PACIFIC BIOTECH COMPANIES, 2023 78
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT,
2021–2023 (USD) 82
TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD) 84
TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 87
TABLE 11 CELL ISOLATION MARKET: ROLE OF RAW MATERIAL VENDORS IN ECOSYSTEM 90
TABLE 12 CELL ISOLATION MARKET: ROLE OF PRODUCT PROVIDERS IN ECOSYSTEM 90
TABLE 13 CELL ISOLATION MARKET: ROLE OF END USERS IN ECOSYSTEM 91
TABLE 14 CELL ISOLATION MARKET: ROLE OF REGULATORY AUTHORITIES IN ECOSYSTEM 91
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 19 REGULATORY GUIDELINES 95
TABLE 20 IMPACT OF PORTER’S FIVE FORCES 98
TABLE 21 KEY CONFERENCES AND EVENTS, 2024–2025 99
TABLE 22 BUYING CRITERIA, BY END USER 102
TABLE 23 IMPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES),
2019–2023 (USD THOUSAND) 103
TABLE 24 IMPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES),
2019–2023 (TONS) 104
TABLE 25 EXPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES),
2019–2023 (USD THOUSAND) 105
TABLE 26 EXPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES),
2019–2023 (TONS) 106
TABLE 27 CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 110
TABLE 28 CELL ISOLATION MARKET FOR CONSUMABLES, BY REGION,
2022–2029 (USD MILLION) 111
TABLE 29 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 30 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY,
2022–2029 (USD MILLION) 112
TABLE 31 ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY,
2022–2029 (USD MILLION) 112
TABLE 32 LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 33 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY REGION,
2022–2029 (USD MILLION) 113
TABLE 34 GCC COUNTRIES: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 35 CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 114
TABLE 36 CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 37 NORTH AMERICA: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 38 EUROPE: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 39 ASIA PACIFIC: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 40 LATIN AMERICA: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 41 MIDDLE EAST: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 42 GCC COUNTRIES: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 43 CELL ISOLATION MARKET FOR BEADS, BY REGION, 2022–2029 (USD MILLION) 118
TABLE 44 NORTH AMERICA: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY,
2022–2029 (USD MILLION) 118
TABLE 45 EUROPE: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY,
2022–2029 (USD MILLION) 119
TABLE 46 ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY,
2022–2029 (USD MILLION) 119
TABLE 47 LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY,
2022–2029 (USD MILLION) 120
TABLE 48 MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY REGION,
2022–2029 (USD MILLION) 120
TABLE 49 GCC COUNTRIES: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY,
2022–2029 (USD MILLION) 120
TABLE 50 CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 121
TABLE 51 CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY REGION,
2022–2029 (USD MILLION) 121
TABLE 52 NORTH AMERICA: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 53 EUROPE: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY,
2022–2029 (USD MILLION) 122
TABLE 54 ASIA PACIFIC: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 55 LATIN AMERICA: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 56 MIDDLE EAST: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 57 GCC COUNTRIES: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 58 CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY REGION,
2022–2029 (USD MILLION) 125
TABLE 59 NORTH AMERICA: CELL ISOLATION MARKET FOR FLUORESCENT BEADS,
BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 60 EUROPE: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 61 ASIA PACIFIC: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 62 LATIN AMERICA: CELL ISOLATION MARKET FOR FLUORESCENT BEADS,
BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 63 MIDDLE EAST: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 64 GCC COUNTRIES: CELL ISOLATION MARKET FOR FLUORESCENT BEADS,
BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 65 CELL ISOLATION MARKET FOR DISPOSABLES, BY REGION,
2022–2029 (USD MILLION) 128
TABLE 66 NORTH AMERICA: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 67 EUROPE: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY,
2022–2029 (USD MILLION) 129
TABLE 68 ASIA PACIFIC: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY,
2022–2029 (USD MILLION) 130
TABLE 69 LATIN AMERICA: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 70 MIDDLE EAST: CELL ISOLATION MARKET FOR DISPOSABLES, BY REGION,
2022–2029 (USD MILLION) 131
TABLE 71 GCC COUNTRIES: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 72 CELL ISOLATION MARKET FOR INSTRUMENTS, BY REGION,
2022–2029 (USD MILLION) 132
TABLE 73 NORTH AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 74 EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 75 ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY,
2022–2029 (USD MILLION) 133
TABLE 76 LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 77 MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY REGION,
2022–2029 (USD MILLION) 134
TABLE 78 GCC COUNTRIES: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 79 CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 135
TABLE 80 CELL ISOLATION MARKET FOR CENTRIFUGES, BY REGION,
2022–2029 (USD MILLION) 136
TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 82 EUROPE: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY,
2022–2029 (USD MILLION) 137
TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY,
2022–2029 (USD MILLION) 137
TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 85 MIDDLE EAST: CELL ISOLATION MARKET FOR CENTRIFUGES, BY REGION,
2022–2029 (USD MILLION) 138
TABLE 86 GCC COUNTRIES: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 87 CELL ISOLATION MARKET FOR CELL SORTERS, BY REGION,
2022–2029 (USD MILLION) 140
TABLE 88 NORTH AMERICA: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 89 EUROPE: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY,
2022–2029 (USD MILLION) 141
TABLE 90 ASIA PACIFIC: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY,
2022–2029 (USD MILLION) 142
TABLE 91 LATIN AMERICA: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 92 MIDDLE EAST: CELL ISOLATION MARKET FOR CELL SORTERS, BY REGION,
2022–2029 (USD MILLION) 143
TABLE 93 GCC COUNTRIES: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 94 CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 95 NORTH AMERICA: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 96 EUROPE: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 97 ASIA PACIFIC: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 98 LATIN AMERICA: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 99 MIDDLE EAST: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 146
TABLE 100 GCC COUNTRIES: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 101 CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY REGION,
2022–2029 (USD MILLION) 148
TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS,
BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 103 EUROPE: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS,
BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 106 MIDDLE EAST: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 150
TABLE 107 GCC COUNTRIES: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS,
BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 108 CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 152
TABLE 109 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION,
2022–2029 (USD MILLION) 153
TABLE 110 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 111 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 154
TABLE 112 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 154
TABLE 113 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 114 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION,
2022–2029 (USD MILLION) 155
TABLE 115 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 116 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 156
TABLE 117 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION,
2022–2029 (USD MILLION) 157
TABLE 118 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 119 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 120 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 121 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 122 MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022–2029 (USD MILLION) 159
TABLE 123 GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 124 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION,
2022–2029 (USD MILLION) 160
TABLE 125 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 126 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 161
TABLE 127 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 162
TABLE 128 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 162
TABLE 129 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION,
2022–2029 (USD MILLION) 163
TABLE 130 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 131 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION,
2022–2029 (USD MILLION) 164
TABLE 132 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 133 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 165
TABLE 134 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY,
2022–2029 (USD MILLION) 165
TABLE 135 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 136 MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION,
2022–2029 (USD MILLION) 166
TABLE 137 GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 138 CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 168
TABLE 139 CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION,
2022–2029 (USD MILLION) 169
TABLE 140 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 141 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY,
2022–2029 (USD MILLION) 170
TABLE 142 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 143 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 144 MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION,
2022–2029 (USD MILLION) 171
TABLE 145 GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 146 CELL ISOLATION MARKET FOR BONE MARROW, BY REGION,
2022–2029 (USD MILLION) 172
TABLE 147 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 148 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY,
2022–2029 (USD MILLION) 173
TABLE 149 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY,
2022–2029 (USD MILLION) 173
TABLE 150 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 151 MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION,
2022–2029 (USD MILLION) 174
TABLE 152 GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 153 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022–2029 (USD MILLION) 175
TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 155 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS,
BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 158 MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022–2029 (USD MILLION) 178
TABLE 159 GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 160 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION,
2022–2029 (USD MILLION) 179
TABLE 161 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES,
BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 162 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 163 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 164 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES,
BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 165 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2022–2029 (USD MILLION) 181
TABLE 166 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES,
BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 167 CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 183
TABLE 168 CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION,
BY REGION, 2022–2029 (USD MILLION) 184
TABLE 169 NORTH AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 170 EUROPE: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 171 ASIA PACIFIC: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 172 LATIN AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 173 MIDDLE EAST: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION) 186
TABLE 174 GCC COUNTRIES: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION) 186
TABLE 175 CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION,
BY REGION, 2022–2029 (USD MILLION) 188
TABLE 176 NORTH AMERICA: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 177 EUROPE: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 178 ASIA PACIFIC: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 179 LATIN AMERICA: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 180 MIDDLE EAST: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION) 190
TABLE 181 GCC COUNTRIES: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 182 CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION) 191
TABLE 183 NORTH AMERICA: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 184 EUROPE: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION,
BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 185 ASIA PACIFIC: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 186 LATIN AMERICA: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 187 MIDDLE EAST: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION) 194
TABLE 188 GCC COUNTRIES: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 189 CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 196
TABLE 190 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION,
2022–2029 (USD MILLION) 197
TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 192 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 193 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 194 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 195 MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY REGION, 2022–2029 (USD MILLION) 199
TABLE 196 GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 197 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION,
2022–2029 (USD MILLION) 200
TABLE 198 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 199 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY,
2022–2029 (USD MILLION) 201
TABLE 200 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 201 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 202 MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 203 GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 204 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION,
2022–2029 (USD MILLION) 204
TABLE 205 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 206 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 207 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 208 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 209 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 210 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 211 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION) 207
TABLE 212 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 213 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 214 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 215 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 216 MIDDLE EAST: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION) 210
TABLE 217 GCC COUNTRIES: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 218 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION,
2022–2029 (USD MILLION) 211
TABLE 219 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 220 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 221 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 222 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 223 MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 213
TABLE 224 GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS,
BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 225 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION,
2022–2029 (USD MILLION) 214
TABLE 226 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 227 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 228 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 229 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 230 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 217
TABLE 231 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 232 CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 219
TABLE 233 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 220
TABLE 234 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 235 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 236 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 237 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 238 MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 223
TABLE 239 GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 223
TABLE 240 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 224
TABLE 241 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 242 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 243 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 244 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 245 MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 227
TABLE 246 GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 247 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY REGION, 2022–2029 (USD MILLION) 228
TABLE 248 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 249 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 229
TABLE 250 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 229
TABLE 251 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 252 MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 230
TABLE 253 GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 254 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION,
2022–2029 (USD MILLION) 231
TABLE 255 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 256 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY,
2022–2029 (USD MILLION) 232
TABLE 257 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 258 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 259 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 233
TABLE 260 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 261 CELL ISOLATION MARKET, BY REGION, 2022–2029 (USD MILLION) 235
TABLE 262 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 237
TABLE 263 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 237
TABLE 264 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 237
TABLE 265 NORTH AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 238
TABLE 266 NORTH AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 238
TABLE 267 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 238
TABLE 268 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 239
TABLE 269 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 239
TABLE 270 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 239
TABLE 271 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 240
TABLE 272 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 240
TABLE 273 US: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 241
TABLE 274 US: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 242
TABLE 275 US: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 276 US: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 242
TABLE 277 US: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 243
TABLE 278 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 243
TABLE 279 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 243
TABLE 280 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 244
TABLE 281 US: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 244
TABLE 282 US: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 245
TABLE 283 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 246
TABLE 284 CANADA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 246
TABLE 285 CANADA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 246
TABLE 286 CANADA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 247
TABLE 287 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 247
TABLE 288 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 247
TABLE 289 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 248
TABLE 290 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 248
TABLE 291 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 249
TABLE 292 CANADA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 249
TABLE 293 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 250
TABLE 294 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 250
TABLE 295 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 251
TABLE 296 EUROPE: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 251
TABLE 297 EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 251
TABLE 298 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 252
TABLE 299 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 252
TABLE 300 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 252
TABLE 301 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 253
TABLE 302 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 253
TABLE 303 EUROPE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 254
TABLE 304 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 255
TABLE 305 GERMANY: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 255
TABLE 306 GERMANY: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 256
TABLE 307 GERMANY: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 256
TABLE 308 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 256
TABLE 309 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 257
TABLE 310 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 257
TABLE 311 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 257
TABLE 312 GERMANY: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 258
TABLE 313 GERMANY: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 258
TABLE 314 UK: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 259
TABLE 315 UK: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 260
TABLE 316 UK: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 317 UK: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 260
TABLE 318 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 261
TABLE 319 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 261
TABLE 320 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 261
TABLE 321 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 262
TABLE 322 UK: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 262
TABLE 323 UK: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 263
TABLE 324 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 264
TABLE 325 FRANCE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 264
TABLE 326 FRANCE: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 264
TABLE 327 FRANCE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 265
TABLE 328 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 265
TABLE 329 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 265
TABLE 330 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 266
TABLE 331 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 266
TABLE 332 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 267
TABLE 333 FRANCE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 267
TABLE 334 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 268
TABLE 335 ITALY: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 269
TABLE 336 ITALY: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 337 ITALY: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 269
TABLE 338 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 270
TABLE 339 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 270
TABLE 340 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 270
TABLE 341 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 271
TABLE 342 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 271
TABLE 343 ITALY: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 272
TABLE 344 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 273
TABLE 345 SPAIN: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 273
TABLE 346 SPAIN: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 273
TABLE 347 SPAIN: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 274
TABLE 348 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 274
TABLE 349 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 274
TABLE 350 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 275
TABLE 351 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 275
TABLE 352 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 276
TABLE 353 SPAIN: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 276
TABLE 354 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 277
TABLE 355 REST OF EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 277
TABLE 356 REST OF EUROPE: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 278
TABLE 357 REST OF EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 278
TABLE 358 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 278
TABLE 359 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 279
TABLE 360 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 279
TABLE 361 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 279
TABLE 362 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 280
TABLE 363 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 280
TABLE 364 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 282
TABLE 365 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 282
TABLE 366 ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 282
TABLE 367 ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 283
TABLE 368 ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 283
TABLE 369 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 283
TABLE 370 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 284
TABLE 371 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 284
TABLE 372 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 284
TABLE 373 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 285
TABLE 374 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 285
TABLE 375 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 286
TABLE 376 CHINA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 287
TABLE 377 CHINA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 287
TABLE 378 CHINA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 287
TABLE 379 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 288
TABLE 380 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 288
TABLE 381 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 288
TABLE 382 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 289
TABLE 383 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 289
TABLE 384 CHINA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 290
TABLE 385 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 291
TABLE 386 JAPAN: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 291
TABLE 387 JAPAN: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 291
TABLE 388 JAPAN: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 292
TABLE 389 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 292
TABLE 390 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 292
TABLE 391 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 293
TABLE 392 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 293
TABLE 393 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 294
TABLE 394 JAPAN: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 294
TABLE 395 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 295
TABLE 396 INDIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 295
TABLE 397 INDIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 296
TABLE 398 INDIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 296
TABLE 399 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 296
TABLE 400 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 297
TABLE 401 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, .2022–2029 (USD MILLION) 297
TABLE 402 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 297
TABLE 403 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 298
TABLE 404 INDIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 298
TABLE 405 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 299
TABLE 406 AUSTRALIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 300
TABLE 407 AUSTRALIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 300
TABLE 408 AUSTRALIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 300
TABLE 409 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 301
TABLE 410 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 301
TABLE 411 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 301
TABLE 412 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 302
TABLE 413 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 302
TABLE 414 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 303
TABLE 415 SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 303
TABLE 416 SOUTH KOREA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 304
TABLE 417 SOUTH KOREA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 304
TABLE 418 SOUTH KOREA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 304
TABLE 419 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 305
TABLE 420 SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 305
TABLE 421 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 305
TABLE 422 SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 306
TABLE 423 SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 306
TABLE 424 SOUTH KOREA: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 307
TABLE 425 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 308
TABLE 426 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 308
TABLE 427 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 308
TABLE 428 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 309
TABLE 429 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 309
TABLE 430 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION) 309
TABLE 431 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 310
TABLE 432 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 310
TABLE 433 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 311
TABLE 434 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 311
TABLE 435 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 312
TABLE 436 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 312
TABLE 437 LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 313
TABLE 438 LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 313
TABLE 439 LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 313
TABLE 440 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 314
TABLE 441 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 314
TABLE 442 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 314
TABLE 443 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 315
TABLE 444 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 315
TABLE 445 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 316
TABLE 446 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 317
TABLE 447 BRAZIL: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 317
TABLE 448 BRAZIL: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 318
TABLE 449 BRAZIL: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 318
TABLE 450 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 318
TABLE 451 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 319
TABLE 452 BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 319
TABLE 453 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 319
TABLE 454 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 320
TABLE 455 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 320
TABLE 456 MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 321
TABLE 457 MEXICO: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 321
TABLE 458 MEXICO: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 322
TABLE 459 MEXICO: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 322
TABLE 460 MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 322
TABLE 461 MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 323
TABLE 462 MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 323
TABLE 463 MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 323
TABLE 464 MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 324
TABLE 465 MEXICO: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 324
TABLE 466 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 325
TABLE 467 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 325
TABLE 468 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 326
TABLE 469 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 326
TABLE 470 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 326
TABLE 471 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION) 327
TABLE 472 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 327
TABLE 473 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 328
TABLE 474 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 328
TABLE 475 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 329
TABLE 476 MIDDLE EAST: CELL ISOLATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 330
TABLE 477 MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 330
TABLE 478 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 330
TABLE 479 MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 331
TABLE 480 MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 331
TABLE 481 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 331
TABLE 482 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 332
TABLE 483 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 332
TABLE 484 MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 332
TABLE 485 MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 333
TABLE 486 MIDDLE EAST: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 333
TABLE 487 GCC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 334
TABLE 488 GCC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 334
TABLE 489 GCC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 335
TABLE 490 GCC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 335
TABLE 491 GCC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 335
TABLE 492 GCC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 336
TABLE 493 GCC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 336
TABLE 494 GCC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 336
TABLE 495 GCC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 337
TABLE 496 GCC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 337
TABLE 497 GCC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 338
TABLE 498 SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 339
TABLE 499 SAUDI ARABIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 339
TABLE 500 SAUDI ARABIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 339
TABLE 501 SAUDI ARABIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 340
TABLE 502 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 340
TABLE 503 SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 340
TABLE 504 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 341
TABLE 505 SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 341
TABLE 506 SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 342
TABLE 507 SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 342
TABLE 508 UAE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 343
TABLE 509 UAE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 343
TABLE 510 UAE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION) 343
TABLE 511 UAE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 344
TABLE 512 UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 344
TABLE 513 UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 344
TABLE 514 UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 345
TABLE 515 UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 345
TABLE 516 UAE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 346
TABLE 517 UAE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 346
TABLE 518 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 347
TABLE 519 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR CONSUMABLES,
BY TYPE, 2022–2029 (USD MILLION) 347
TABLE 520 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 347
TABLE 521 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 348
TABLE 522 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 348
TABLE 523 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION) 348
TABLE 524 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 349
TABLE 525 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 349
TABLE 526 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 350
TABLE 527 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 350
TABLE 528 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 351
TABLE 529 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 351
TABLE 530 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 352
TABLE 531 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 352
TABLE 532 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE,
2022–2029 (USD MILLION) 352
TABLE 533 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION) 353
TABLE 534 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE,
2022–2029 (USD MILLION) 353
TABLE 535 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE,
2022–2029 (USD MILLION) 354
TABLE 536 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 354
TABLE 537 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER,
2022–2029 (USD MILLION) 355
TABLE 538 AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 355
TABLE 539 AFRICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE,
2022–2029 (USD MILLION) 356
TABLE 540 AFRICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE,
2022–2029 (USD MILLION) 356
TABLE 541 AFRICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE,
2022–2029 (USD MILLION) 356
TABLE 542 AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 357
TABLE 543 AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2022–2029 (USD MILLION) 357
TABLE 544 AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION) 357
TABLE 545 AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 358
TABLE 546 AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 358
TABLE 547 AFRICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION) 359
TABLE 548 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 361
TABLE 549 CELL ISOLATION MARKET: DEGREE OF COMPETITION 364
TABLE 550 CELL ISOLATION MARKET: REGION FOOTPRINT 369
TABLE 551 CELL ISOLATION MARKET: PRODUCT FOOTPRINT 370
TABLE 552 CELL ISOLATION MARKET: CELL TYPE FOOTPRINT 371
TABLE 553 CELL ISOLATION MARKET: END USER FOOTPRINT 372
TABLE 554 CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 375
TABLE 555 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 376
TABLE 556 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 379
TABLE 557 CELL ISOLATION MARKET: DEALS, JANUARY 2021–JUNE 2024 380
TABLE 558 CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024 381
TABLE 559 CELL ISOLATION MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 382
TABLE 560 DANAHER CORPORATION: COMPANY OVERVIEW 383
TABLE 561 DANAHER CORPORATION: PRODUCTS OFFERED 384
TABLE 562 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024 385
TABLE 563 MERCK KGAA: COMPANY OVERVIEW 387
TABLE 564 MERCK KGAA: PRODUCTS OFFERED 388
TABLE 565 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024 389
TABLE 566 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024 389
TABLE 567 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 391
TABLE 568 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 393
TABLE 569 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,
JANUARY 2021–JUNE 2024 397
TABLE 570 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024 398
TABLE 571 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024 399
TABLE 572 BD: COMPANY OVERVIEW 400
TABLE 573 BD: PRODUCTS OFFERED 401
TABLE 574 BD: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 404
TABLE 575 BD: DEALS, JANUARY 2021–JUNE 2024 404
TABLE 576 BD: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 405
TABLE 577 SARTORIUS AG: COMPANY OVERVIEW 406
TABLE 578 SARTORIUS AG: PRODUCTS OFFERED 407
TABLE 579 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024 409
TABLE 580 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 410
TABLE 581 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 411
TABLE 582 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–JUNE 2024 412
TABLE 583 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 413
TABLE 584 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 415
TABLE 585 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 416
TABLE 586 QIAGEN: COMPANY OVERVIEW 417
TABLE 587 QIAGEN: PRODUCTS OFFERED 418
TABLE 588 QIAGEN: DEALS, JANUARY 2021–JUNE 2024 419
TABLE 589 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 420
TABLE 590 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 422
TABLE 591 REVVITY: COMPANY OVERVIEW 423
TABLE 592 REVVITY: PRODUCTS OFFERED 425
TABLE 593 REVVITY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 427
TABLE 594 CORNING INCORPORATED: COMPANY OVERVIEW 428
TABLE 595 CORNING INCORPORATED: PRODUCTS OFFERED 430
TABLE 596 LONZA: COMPANY OVERVIEW 431
TABLE 597 LONZA: PRODUCTS OFFERED 432
TABLE 598 LONZA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 433
TABLE 599 LONZA: DEALS, JANUARY 2021–JUNE 2024 433
TABLE 600 BIO-TECHNE: COMPANY OVERVIEW 434
TABLE 601 BIO-TECHNE: PRODUCTS OFFERED 435
TABLE 602 BIO-TECHNE: DEALS, JANUARY 2021–JUNE 2024 437
TABLE 603 BIO-TECHNE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 437
TABLE 604 TERUMO CORPORATION: COMPANY OVERVIEW 438
TABLE 605 TERUMO CORPORATION: PRODUCTS OFFERED 440
TABLE 606 TERUMO CORPORATION: DEALS, JANUARY 2021–JUNE 2024 440
TABLE 607 MILTENYI BIOTEC: COMPANY OVERVIEW 441
TABLE 608 MILTENYI BIOTEC: PRODUCTS OFFERED 441
TABLE 609 TAKARA BIO INC.: COMPANY OVERVIEW 443
TABLE 610 TAKARA BIO INC.: PRODUCTS OFFERED 444
TABLE 611 TAKARA BIO INC.: DEALS, JANUARY 2021–JUNE 2024 446
TABLE 612 GENSCRIPT: COMPANY OVERVIEW 447
TABLE 613 GENSCRIPT: PRODUCTS OFFERED 448
TABLE 614 GENSCRIPT: DEALS, JANUARY 2021–JUNE 2024 450
TABLE 615 STANDARD BIOTOOLS: COMPANY OVERVIEW 451
TABLE 616 STANDARD BIOTOOLS: PRODUCTS OFFERED 452
TABLE 617 ALFA LAVAL: COMPANY OVERVIEW 453
TABLE 618 ALFA LAVAL: PRODUCTS OFFERED 454
TABLE 619 ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024 455
TABLE 620 ALFA LAVAL: DEALS, JANUARY 2021–JUNE 2024 456
TABLE 621 PROMEGA CORPORATION: COMPANY OVERVIEW 457
TABLE 622 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 458
TABLE 623 MICAREO INC.: COMPANY OVERVIEW 458
TABLE 624 APPLIED CELLS INC.: COMPANY OVERVIEW 459
TABLE 625 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW 460
TABLE 626 CREATIVE BIOARRAY: COMPANY OVERVIEW 461
TABLE 627 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW 461
TABLE 628 MAGBIO GENOMICS, INC.: COMPANY OVERVIEW 462
TABLE 629 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW 463
TABLE 630 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG:
COMPANY OVERVIEW 464
TABLE 631 INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW 465
LIST OF FIGURES
FIGURE 1 CELL ISOLATION MARKET SEGMENTATION 43
FIGURE 2 RESEARCH DESIGN 47
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS 49
FIGURE 4 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 50
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED
ESTIMATION, 2023 51
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE
ANALYSIS, 2023 51
FIGURE 7 INSIGHTS FROM PRIMARY SOURCES 53
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 53
FIGURE 9 CELL ISOLATION MARKET: CAGR PROJECTIONS 55
FIGURE 10 DATA TRIANGULATION 57
FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 61
FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION) 62
FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2024 VS. 2029 (USD MILLION) 62
FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION) 63
FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 64
FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 64
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET 65
FIGURE 18 INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH AND GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET 67
FIGURE 19 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN CELL ISOLATION MARKET IN 2023 68
FIGURE 20 BIOMOLECULE ISOLATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 69
FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2023 69
FIGURE 22 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 70
FIGURE 23 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
FIGURE 24 GLOBAL HIV EPIDEMIC, 2022 74
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS 80
FIGURE 26 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE,
2021–2023 (USD) 83
FIGURE 27 VALUE CHAIN ANALYSIS 85
FIGURE 28 PATENT ANALYSIS, 2014–2024 86
FIGURE 29 SUPPLY CHAIN ANALYSIS 89
FIGURE 30 ECOSYSTEM ANALYSIS 89
FIGURE 31 PORTER’S FIVE FORCES 97
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 101
FIGURE 33 BUYING CRITERIA, BY END USER 102
FIGURE 34 FLUORESCENCE-ACTIVATED CELL SORTERS MARKET, 2022–2029 (UNITS) 140
FIGURE 35 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT 236
FIGURE 36 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT 281
FIGURE 37 REVENUE ANALYSIS OF TOP 4 PLAYERS, 2021–2023 (USD MILLION) 363
FIGURE 38 MARKET SHARE ANALYSIS, 2023 364
FIGURE 39 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 367
FIGURE 40 CELL ISOLATION MARKET: COMPANY FOOTPRINT 368
FIGURE 41 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 374
FIGURE 42 COMPANY VALUATION 377
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 377
FIGURE 44 CELL ISOLATION MARKET: BRAND/PRODUCT COMPARISON 378
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 384
FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023) 388
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 392
FIGURE 48 BD: COMPANY SNAPSHOT (2023) 401
FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2023) 407
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 411
FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 414
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2023) 418
FIGURE 53 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 421
FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023) 424
FIGURE 55 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 429
FIGURE 56 LONZA: COMPANY SNAPSHOT (2023) 432
FIGURE 57 BIO-TECHNE: COMPANY SNAPSHOT (2023) 435
FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 439
FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT (2023) 444
FIGURE 60 GENSCRIPT: COMPANY SNAPSHOT (2023) 448
FIGURE 61 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023) 452
FIGURE 62 ALFA LAVAL: COMPANY SNAPSHOT (2023) 454
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11